We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+26.89%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$352M
AUM Growth
+$55.2M
Cap. Flow
+$908K
Cap. Flow %
0.26%
Top 10 Hldgs %
80.62%
Holding
64
New
1
Increased
7
Reduced
6
Closed
4

Top Buys

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$3.25M
2
PGNY icon
Progyny
PGNY
+$2.09M
3
MNDY icon
monday.com
MNDY
+$1.98M
4
GTM
ZoomInfo Technologies
GTM
+$1.84M
5
HOOD icon
Robinhood
HOOD
+$1.77M

Sector Composition

Rank Sector Weight
1 Technology 57.14%
2 Consumer Discretionary 23.1%
3 Healthcare 10.67%
4 Financials 3.27%
5 Communication Services 1.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOCN icon
26
DigitalOcean
DOCN
$13.2B
$1.77M 0.5%
44,210
IAS
27
DELISTED
Integral Ad Science
IAS
$1.74M 0.49%
96,779
-208,519
-68% -$3.52M
DOCS icon
28
Doximity
DOCS
$3.85B
$1.69M 0.48%
49,804
AMPL icon
29
Amplitude
AMPL
$1.16B
$1.68M 0.48%
153,018
PATH icon
30
UiPath
PATH
$6.32B
$1.68M 0.48%
101,380
+37,680
+59% +$604K
FROG icon
31
JFrog
FROG
$9.26B
$1.63M 0.46%
59,008
U icon
32
Unity
U
$13.9B
$1.48M 0.42%
34,194
AXLA
33
DELISTED
Axcella Health Inc. Common Stock
AXLA
$1.36M 0.38%
248,317
SGTX
34
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$1.28M 0.36%
56,979
-1
-0% -$7
EB
35
DELISTED
Eventbrite
EB
$976K 0.28%
102,164
IBRX icon
36
ImmunityBio
IBRX
$7.3B
$933K 0.27%
335,709
TWLO icon
37
Twilio
TWLO
$29.5B
$927K 0.26%
14,572
PLRX icon
38
Pliant Therapeutics
PLRX
$66.3M
$896K 0.25%
+49,434
New +$1.17M
ONTF
39
DELISTED
ON24
ONTF
$887K 0.25%
109,210
HNST icon
40
The Honest Company
HNST
$421M
$799K 0.23%
475,629
DIBS icon
41
1stdibs.com
DIBS
$146M
$746K 0.21%
199,496
NEUE
42
DELISTED
NeueHealth
NEUE
$644K 0.18%
52,720
-1
-0% -$13
PINS icon
43
Pinterest
PINS
$13.6B
$583K 0.17%
21,310
EVLO
44
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$498K 0.14%
153,175
CPNG icon
45
Coupang
CPNG
$27.7B
$467K 0.13%
26,834
PACB icon
46
Pacific Biosciences
PACB
$432M
$312K 0.09%
23,484
MCRB icon
47
Seres Therapeutics
MCRB
$46.5M
$236K 0.07%
2,468
QS icon
48
QuantumScape Corp
QS
$3.18B
$231K 0.07%
28,951
DASH icon
49
DoorDash
DASH
$85.2B
$191K 0.05%
2,505
OPEN icon
50
Opendoor
OPEN
$3.8B
$188K 0.05%
48,264

Similar funds

Harbourvest Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Harbourvest Partners held 64 positions worth $352M, up 19% from $297M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Harbourvest Partners's Q2 2023 filing shows 1 new, 7 increased, 6 reduced and 4 closed positions. Its largest new stake was Pliant Therapeutics: 49,434 shares worth $896K. The largest sale was N-able, an estimated $4.41M.

By sector, the portfolio is most concentrated in Technology at 57% of assets, down from 60% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Harbourvest Partners's largest Q2 2023 buy was Pliant Therapeutics: 49,434 shares worth $896K.
  • Harbourvest Partners added most to Affirm in Q2 2023, an estimated $3.25M increase.
  • Harbourvest Partners's biggest Q2 2023 reduction was N-able, cutting an estimated $4.41M.
  • Harbourvest Partners fully exited TH International in Q2 2023, selling an estimated $2.43M.
  • Harbourvest Partners's ten largest holdings make up 81% of its $352M portfolio in Q2 2023.
  • Harbourvest Partners opened 1 new position and closed 4 in Q2 2023.
  • Harbourvest Partners's portfolio value rose 19% quarter-over-quarter to $352M.

Based on Harbourvest Partners's 13F filing for Q2 2023, filed 14 Aug 2023.